文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

利用深度学习和计算组织病理学增强皮肤鳞状细胞癌转移风险预测

Enhanced metastasis risk prediction in cutaneous squamous cell carcinoma using deep learning and computational histopathology.

作者信息

Peleva Emilia, Chen Yue, Finke Bernhard, Rizvi Hasan, Healy Eugene, Lai Chester, Craig Paul, Rickaby William, Schoenherr Christina, Nourse Craig, Proby Charlotte, Inman Gareth J, Leigh Irene M, Harwood Catherine A, Wang Jun

机构信息

Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK.

Dermatology, The Royal London Hospital, Barts Health NHS Trust, London, UK.

出版信息

NPJ Precis Oncol. 2025 Sep 2;9(1):308. doi: 10.1038/s41698-025-01065-7.


DOI:10.1038/s41698-025-01065-7
PMID:40897830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12405460/
Abstract

Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer with metastatic potential and development of metastases carries a poor prognosis. To address the need for reliable risk stratification, we developed cSCCNet, a deep learning model using digital pathology of primary cSCC to predict metastatic risk. A retrospective cohort of 227 primary cSCC from four centres is used for model development. cSCCNet automatically selects the tumour area in standard histopathological slides and then stratifies primary cSCC into high- vs. low-risk categories, with heatmaps indicating most predictive tiles contributing to explainability. On a 20% hold-out testing cohort, cSCCNet achieves an area under the curve (AUC) of 0.95 and 95% accuracy in predicting risk of metastasis, outperforming gene expression-based tools and clinicopathologic classifications. Multivariate analysis including common clinicopathologic classifications confirms cSCCNet as an independent predictor for metastasis, implying it identifies predictive features beyond known clinicopathologic risk factors. Histopathological analysis including multiplex immunohistochemistry suggests that tumour differentiation, acantholysis, desmoplasia, and the spatial localisation of lymphocytes relative to tumour tissue may be important in predicting risk of developing metastasis. Although further validation including prospective evaluation is required, cSCCNet has potential as a reliable and accurate tool for metastatic risk prediction that could be easily integrated into existing histopathology workflows.

摘要

皮肤鳞状细胞癌(cSCC)是最常见的具有转移潜能的皮肤癌,发生转移时预后较差。为满足可靠风险分层的需求,我们开发了cSCCNet,这是一种利用原发性cSCC的数字病理学来预测转移风险的深度学习模型。来自四个中心的227例原发性cSCC的回顾性队列用于模型开发。cSCCNet会自动在标准组织病理学切片中选择肿瘤区域,然后将原发性cSCC分为高风险和低风险类别,热图显示了有助于解释的最具预测性的切片。在20%的留出测试队列中,cSCCNet在预测转移风险方面的曲线下面积(AUC)为0.95,准确率为95%,优于基于基因表达的工具和临床病理分类。包括常见临床病理分类在内的多变量分析证实cSCCNet是转移的独立预测因子,这意味着它识别出了已知临床病理风险因素之外的预测特征。包括多重免疫组化在内的组织病理学分析表明,肿瘤分化、棘层松解、促纤维增生以及淋巴细胞相对于肿瘤组织的空间定位可能在预测转移风险方面具有重要意义。尽管需要进一步验证,包括前瞻性评估,但cSCCNet有潜力成为一种可靠且准确的转移风险预测工具,可轻松整合到现有的组织病理学工作流程中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/15db1b56cd23/41698_2025_1065_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/330e9f72b8e4/41698_2025_1065_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/5b2928ecff14/41698_2025_1065_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/19a584800ed1/41698_2025_1065_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/76ca26ee8474/41698_2025_1065_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/15db1b56cd23/41698_2025_1065_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/330e9f72b8e4/41698_2025_1065_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/5b2928ecff14/41698_2025_1065_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/19a584800ed1/41698_2025_1065_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/76ca26ee8474/41698_2025_1065_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8d/12405460/15db1b56cd23/41698_2025_1065_Fig5_HTML.jpg

相似文献

[1]
Enhanced metastasis risk prediction in cutaneous squamous cell carcinoma using deep learning and computational histopathology.

NPJ Precis Oncol. 2025-9-2

[2]
The landscape of long non-coding RNA during cSCC progression.

Br J Dermatol. 2025-3-27

[3]
A deep learning algorithm to detect cutaneous squamous cell carcinoma on frozen sections in Mohs micrographic surgery: a retrospective assessment.

medRxiv. 2023-5-16

[4]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[5]
Sun protection for preventing basal cell and squamous cell skin cancers.

Cochrane Database Syst Rev. 2016-7-25

[6]
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?

Clin Orthop Relat Res. 2024-9-1

[7]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[8]
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling.

Br J Dermatol. 2024-12-23

[9]
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.

Clin Orthop Relat Res. 2024-12-1

[10]
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.

Clin Orthop Relat Res. 2024-1-1

本文引用的文献

[1]
Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma.

NPJ Precis Oncol. 2025-6-28

[2]
riSCC: A personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma.

J Am Acad Dermatol. 2025-7

[3]
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosis.

NPJ Digit Med. 2025-2-15

[4]
Skin cancer in Europe today and challenges for tomorrow.

J Eur Acad Dermatol Venereol. 2025-2

[5]
Automated cutaneous squamous cell carcinoma grading using deep learning with transfer learning.

Rom J Morphol Embryol. 2024

[6]
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 Update.

Radiol Artif Intell. 2024-7

[7]
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.

BMJ. 2024-4-16

[8]
International melanoma and non melanoma skin cancer mortality trends: is it time to refocus our attention?

Clin Exp Dermatol. 2024-4-23

[9]
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.

EClinicalMedicine. 2023-8-19

[10]
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

J Pathol. 2023-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索